The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy
Open accessAbstract
BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected individuals receiving potent antiretroviral therapy (ART) shows high variability. We studied the determinants and the clinical relevance of incomplete CD4 T cell restoration. METHODS: Longitudinal CD4 T cell count was analyzed in 293 participants of the Swiss HIV Cohort Study who had had a plasma HIV-1 RNA load <1000 copies/mL for > or =5 years. CD4 T cell recovery was stratified by CD4 T cell count 5 years after initiation of ART (> or =500 cells/microL was defined as a complete response, and <500 cells/microL was defined as an incomplete response). Determinants of incomplete responses and clinical events were evaluated using logistic regression and survival analyses. RESULTS: The median CD4 T cell count increased from 180 cells/microL at baseline to 576 cells/microL 5 years after ART initiation. A total of 35.8% of patients were incomplete responders, of whom 47.6% reached a CD4 T cell plateau <500 cells/microL. Centers for Disease Control and Prevention HIV-1 disease category B and/or C events occurred in 21% of incomplete responders and in 14.4% of complete responders (P>.05). Older age (adjusted odds ratio [aOR], 1.71 per 10-year increase; 95% confidence interval [CI], 1.21-2.43), lower baseline CD4 T cell count (aOR, 0.37 per 100-cell increase; 95% CI, 0.28-0.49), and longer duration of HIV infection (aOR, 2.39 per 10-year increase; 95% CI, 1.19-4.81) were significantly associated with a CD4 T cell count <500 cells/microL at 5 years. The median increases in CD4 T cell count after 3-6 months of ART were smaller in incomplete responders (P<.001) and predicted, in conjunction with baseline CD4 T cell count and age, incomplete response with 80% sensitivity and 72% specificity. CONCLUSION: Individuals with incomplete CD4 T cell recovery to <500 cells/microL had more advanced HIV-1 infection at baseline. CD4 T cell changes during the first 3-6 months of ART already reflect the capacity of the immune system to replenish depleted CD4 T lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Self-citationLedergerber, B., Egger, M., Opravil, M., Telenti, A., Hirschel, B., Battegay, M., Vernazza, P., Sudre, P., Flepp, M., Furrer, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01122-8 · Cited by 906
Self-citationGreub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Burgisser, P., Erb, P., Boggian, K., Piffaretti, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03232-3 · Cited by 894
Self-citationHunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
French, M. A., Lenzo, N., John, M., Mallal, S. A., McKinnon, E. J., James, I. R., Price, P., Flexman, J. P., & Tay‐Kearney, M. (2000) · HIV Medicine · doi:10.1046/j.1468-1293.2000.00012.x · Cited by 413
Kaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409
Self-citationBucy, R. P., Hockett, R. D., Derdeyn, C. A., Saag, M. S., Squires, K., Sillers, M., Mitsuyasu, R. T., & Kilby, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5863 · Cited by 329
Immune Reconstitution in HIV‐Infected Patients
Hirsch, H. H., Kaufmann, G., Sendi, P., & Battegay, M. (2004) · Clinical Infectious Diseases · doi:10.1086/383034 · Cited by 327
Self-citationKelleher, A. D., Carr, A., Zaunders, J., & Cooper, D. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.321 · Cited by 323
Hunt, P. W., Deeks, S. G., Rodriguez, B., Valdez, H., Shade, S. B., Abrams, D. I., Kitahata, M. M., Krone, M., Neilands, T. B., Brand, R. J., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00009 · Cited by 273
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
Teixeira, L., Valdez, H., McCune, J. M., Koup, R. A., Badley, A. D., Hellerstein, M. K., Napolitano, L. A., Douek, D. C., Mbisa, G., Deeks, S., et al. (2001) · AIDS · doi:10.1097/00002030-200109280-00002 · Cited by 249
Apoptosis as an HIV strategy to escape immune attack
Gougeon, M.-L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1087 · Cited by 222
Valdez, H., Connick, E., Smith, K. Y., Lederman, M. M., Bosch, R. J., Kim, R. S., St. Clair, M., Kuritzkes, D. R., Kessler, H., Fox, L., et al. (2002) · AIDS · doi:10.1097/00002030-200209270-00002 · Cited by 211
Kaufmann, G. R., Bloch, M., Finlayson, R., Zaunders, J., Smith, D., & Cooper, D. A. (2002) · AIDS · doi:10.1097/00002030-200202150-00007 · Cited by 169
Self-citationOpravil, M., Hirschel, B. J., Lazzarin, A., Furrer, H., Chave, J., Yerly, S., Bisset, L. R., Fischer, M., Vernazza, P., Bernasconi, E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340312 · Cited by 134
Self-citationTarwater, P. M., Margolick, J. B., Jin, J., Phair, J. P., Detels, R., Rinaldo, C. R., Giorgi, J. V., & Muñoz, A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200106010-00012 · Cited by 115
Opravil, M., Ledergerber, B., Furrer, H., Hirschel, B. J., Imhof, A., Gallant, S., Wagels, T., Bernasconi, E., Meienberg, F., Rickenbach, M., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00009 · Cited by 111
Self-citationDeeks, S. G., Hoh, R., Grant, R. M., Wrin, T., Barbour, J. D., Narvaez, A., Cesar, D., Abe, K., Hanley, M. B., Hellmann, N. S., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338467 · Cited by 107
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
Kaufmann, G. R., Bloch, M., Zaunders, J., Smith, D. E., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200005260-00007 · Cited by 101
Self-citationKaufmann, G. R., Zaunders, J., Cunningham, P., Kelleher, A. D., Grey, P., Smith, D. E., Carr, A. J., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200012010-00003 · Cited by 97
Self-citationT cell changes after combined nucleoside analogue therapy in HIV primary infection
Carcelain, G., Blanc, C., Leibowitch, J., et al. (1999) · AIDS · doi:10.1097/00002030-199906180-00011 · Cited by 49
Lewin, S. R., Ribeiro, R. M., Kaufmann, G. R., Smith, D. E., Zaunders, J., Law, M. G., Solomon, A. E., Cameron, P. U., Cooper, D. A., & Perelson, A. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4657 · Cited by 49
Self-citationKaufmann, G. R., Zaunders, J., Murray, J. M., Kelleher, A. D., Lewin, S. R., Solomon, A. E., Smith, D. E., & Cooper, D. A. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220150217238 · Cited by 22
Self-citation
Cited by
Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., Huebner, R. E., Janoff, E. N., Justice, A. C., Kuritzkes, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590150 · Cited by 539
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Kelley, C. F., Kitchen, C. M. R., Hunt, P. W., Rodriguez, B., Hecht, F. M., Kitahata, M., Crane, H. M., Willig, J., Mugavero, M., Saag, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597093 · Cited by 407
Lewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin, J.-L., Katlama, C., Dabis, F., & Leport, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318134257a · Cited by 402
Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
Levy, Y., Lacabaratz, C., Weiss, L., Viard, J.-P., Goujard, C., Lelièvre, J.-D., Boué, F., Molina, J.-M., Rouzioux, C., Avettand-Fénoêl, V., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38052 · Cited by 381
Metadata
- Authors
- Kaufmann, G. R., Furrer, H., Ledergerber, B., Perrin, L., Opravil, M., Vernazza, P., Cavassini, M., Bernasconi, E., Rickenbach, M., Hirschel, B., Battegay, M., & Study, S. H. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-01
- Volume
- 41
- Issue
- 3
- Pages
- 361-372
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2140606947
- Cited by
- 313
- References
- 24
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.